THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
95,559,938
Share change
+298,862
Total reported value
$425,226,112
Price per share
$4.45
Number of holders
79
Value change
+$1,098,617
Number of buys
35
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q4 2014

As of 31 Dec 2014, THERAPEUTICSMD INC - COM (TXMD) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,559,938 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Bank of New York Mellon Corp, GILDER GAGNON HOWE & CO LLC, BlackRock Fund Advisors, State Street Corp, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and RA CAPITAL MANAGEMENT, LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.